UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
98 hedge funds and large institutions have $83.8M invested in Unity Biotechnology in 2021 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+6
Holders Change %
+6.52%
% of All Funds
1.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
29
Increased
16
Reduced
24
Closed
23
Calls
$1.41M
Puts
$474K
Net Calls
+$936K
Net Calls Change
+$668K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$4.24M |
| 2 |
2
Millennium Management
New York
|
$2.81M |
| 3 |
3
Renaissance Technologies
New York
|
$2.38M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.2M |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$1.06M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$4.09M |
| 2 |
2
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$10.7M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$477K |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$284K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.42M |
